AI Article Synopsis

  • Kidney tubular health is a significant predictor of chronic kidney disease (CKD) progression, but it’s not well-measured by standard metrics like eGFR and albuminuria.
  • The study involved 2,428 participants with CKD, measuring urinary biomarkers (uromodulin, β2-microglobulin, α1-microglobulin) to see how they related to declines in eGFR.
  • Results showed that higher uromodulin was linked to slower eGFR decline, while higher β2-microglobulin indicated faster decline; however, these associations were less clear in participants undergoing intensive blood pressure treatment.

Article Abstract

Background: Kidney tubular atrophy on biopsy is a strong predictor of chronic kidney disease (CKD) progression, but tubular health is poorly quantified by traditional measures including estimated glomerular filtration rate (eGFR) and albuminuria. We hypothesized that urinary biomarkers of impaired tubule function would be associated with faster eGFR declines in persons with CKD.

Methods: We measured baseline urine concentrations of uromodulin, β2-microglobulin (β2m), and α1-microglobulin (α1m) among 2,428 participants of the Systolic Blood Pressure Intervention Trial with an eGFR <60 mL/min/1.73 m2. We used linear mixed models to evaluate biomarker associations with annualized relative change in eGFR, stratified by randomization arm.

Results: At baseline, the mean age was 73 ± 9 years and eGFR was 46 ± 11 mL/min/1.73 m2. In the standard blood pressure treatment arm, each 2-fold higher urinary uromodulin was associated with slower % annual eGFR decline (0.34 [95% CI: 0.08, 0.60]), whereas higher urinary β2m was associated with faster % annual eGFR decline (-0.10 [95% CI: -0.18, -0.02]) in multivariable-adjusted models including baseline eGFR and albuminuria. Associations were weaker and did not reach statistical significance in the intensive blood pressure treatment arm for either uromodulin (0.11 [-0.13, 0.35], p value for interaction by treatment arm = 0.045) or β2m (-0.01 [-0.08, 0.08], p value for interaction = 0.001). Urinary α1m was not independently associated with eGFR decline in the standard (0.01 [-0.22, 0.23]) or intensive (0.03 [-0.20, 0.25]) arm.

Conclusions: Among trial participants with hypertension and CKD, baseline measures of tubular function were associated with subsequent declines in kidney function, although these associations were diminished by intensive blood pressure control.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606644PMC
http://dx.doi.org/10.1159/000509978DOI Listing

Publication Analysis

Top Keywords

chronic kidney
8
kidney disease
8
tubular biomarkers
4
biomarkers chronic
4
disease progression
4
progression sprint
4
sprint participants
4
participants background
4
background kidney
4
kidney tubular
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!